APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fosfomycin Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fosfomycin Sodium Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchFosfomycin Sodium Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Fosfomycin Sodium Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Fosfomycin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fosfomycin Sodium Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Fosfomycin Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Fosfomycin Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fosfomycin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fosfomycin Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fosfomycin Sodium market include New Asia Pharma, Dorrapharma, Merck KGaA, FarmaSino Pharmaceutical, Hubei Xunda Pharmaceutical, Northeast Pharma, Sundent Pharm Group, Shin Poong Pharm and National Analytical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fosfomycin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fosfomycin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fosfomycin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fosfomycin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Fosfomycin Sodium Segment by Company

New Asia Pharma

Dorrapharma

Merck KGaA

FarmaSino Pharmaceutical

Hubei Xunda Pharmaceutical

Northeast Pharma

Sundent Pharm Group

Shin Poong Pharm

National Analytical Corporation

Ercros

Fosfomycin Sodium Segment by Type

Tablets

Injection

Fosfomycin Sodium Segment by Application

Hospital

Clinic

Other

Fosfomycin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fosfomycin Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fosfomycin Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fosfomycin Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Fosfomycin Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fosfomycin Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fosfomycin Sodium industry.

Chapter 3: Detailed analysis of Fosfomycin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fosfomycin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fosfomycin Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fosfomycin Sodium Industry Trends Table 2. Fosfomycin Sodium Industry Drivers Table 3. Fosfomycin Sodium Industry Opportunities and Challenges Table 4. Fosfomycin Sodium Industry Restraints Table 5. Global Fosfomycin Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fosfomycin Sodium Revenue Share by Company (2021-2026) Table 7. Global Fosfomycin Sodium Sales Volume by Company (k units) & (2021-2026) Table 8. Global Fosfomycin Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Fosfomycin Sodium Average Price (US$/unit) of Company (2021-2026) Table 10. Global Fosfomycin Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fosfomycin Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Fosfomycin Sodium Company, Product Type & Application Table 13. Global Fosfomycin Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fosfomycin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Injection Table 19. Global Fosfomycin Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Fosfomycin Sodium Sales Volume by Type (2021-2026) & (k units) Table 21. Global Fosfomycin Sodium Sales Volume by Type (2027-2032) & (k units) Table 22. Global Fosfomycin Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Fosfomycin Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Fosfomycin Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fosfomycin Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fosfomycin Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fosfomycin Sodium Sales Value Share by Type (2021-2026) Table 28. Global Fosfomycin Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Fosfomycin Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Fosfomycin Sodium Sales Volume by Application (2021-2026) & (k units) Table 34. Global Fosfomycin Sodium Sales Volume by Application (2027-2032) & (k units) Table 35. Global Fosfomycin Sodium Sales Volume Share by Application (2021-2026) Table 36. Global Fosfomycin Sodium Sales Volume Share by Application (2027-2032) Table 37. Global Fosfomycin Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Fosfomycin Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Fosfomycin Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Fosfomycin Sodium Sales Value Share by Application (2021-2026) Table 41. Global Fosfomycin Sodium Sales Value Share by Application (2027-2032) Table 42. Global Fosfomycin Sodium Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Fosfomycin Sodium Sales by Region (2021-2026) & (k units) Table 44. Global Fosfomycin Sodium Sales Market Share by Region (2021-2026) Table 45. Global Fosfomycin Sodium Sales by Region (2027-2032) & (k units) Table 46. Global Fosfomycin Sodium Sales Market Share by Region (2027-2032) Table 47. Global Fosfomycin Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Fosfomycin Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Fosfomycin Sodium Sales Value Share by Region (2021-2026) Table 50. Global Fosfomycin Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Fosfomycin Sodium Sales Value Share by Region (2027-2032) Table 52. Global Fosfomycin Sodium Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Fosfomycin Sodium Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Fosfomycin Sodium Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Fosfomycin Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Fosfomycin Sodium Sales by Country (2021-2026) & (k units) Table 57. Global Fosfomycin Sodium Sales Market Share by Country (2021-2026) Table 58. Global Fosfomycin Sodium Sales by Country (2027-2032) & (k units) Table 59. Global Fosfomycin Sodium Sales Market Share by Country (2027-2032) Table 60. Global Fosfomycin Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Fosfomycin Sodium Sales Value Market Share by Country (2021-2026) Table 62. Global Fosfomycin Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Fosfomycin Sodium Sales Value Market Share by Country (2027-2032) Table 64. New Asia Pharma Company Information Table 65. New Asia Pharma Business Overview Table 66. New Asia Pharma Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. New Asia Pharma Fosfomycin Sodium Product Portfolio Table 68. New Asia Pharma Recent Development Table 69. Dorrapharma Company Information Table 70. Dorrapharma Business Overview Table 71. Dorrapharma Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Dorrapharma Fosfomycin Sodium Product Portfolio Table 73. Dorrapharma Recent Development Table 74. Merck KGaA Company Information Table 75. Merck KGaA Business Overview Table 76. Merck KGaA Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck KGaA Fosfomycin Sodium Product Portfolio Table 78. Merck KGaA Recent Development Table 79. FarmaSino Pharmaceutical Company Information Table 80. FarmaSino Pharmaceutical Business Overview Table 81. FarmaSino Pharmaceutical Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio Table 83. FarmaSino Pharmaceutical Recent Development Table 84. Hubei Xunda Pharmaceutical Company Information Table 85. Hubei Xunda Pharmaceutical Business Overview Table 86. Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio Table 88. Hubei Xunda Pharmaceutical Recent Development Table 89. Northeast Pharma Company Information Table 90. Northeast Pharma Business Overview Table 91. Northeast Pharma Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Northeast Pharma Fosfomycin Sodium Product Portfolio Table 93. Northeast Pharma Recent Development Table 94. Sundent Pharm Group Company Information Table 95. Sundent Pharm Group Business Overview Table 96. Sundent Pharm Group Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Sundent Pharm Group Fosfomycin Sodium Product Portfolio Table 98. Sundent Pharm Group Recent Development Table 99. Shin Poong Pharm Company Information Table 100. Shin Poong Pharm Business Overview Table 101. Shin Poong Pharm Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Shin Poong Pharm Fosfomycin Sodium Product Portfolio Table 103. Shin Poong Pharm Recent Development Table 104. National Analytical Corporation Company Information Table 105. National Analytical Corporation Business Overview Table 106. National Analytical Corporation Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. National Analytical Corporation Fosfomycin Sodium Product Portfolio Table 108. National Analytical Corporation Recent Development Table 109. Ercros Company Information Table 110. Ercros Business Overview Table 111. Ercros Fosfomycin Sodium Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Ercros Fosfomycin Sodium Product Portfolio Table 113. Ercros Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Fosfomycin Sodium Distributors List Table 117. Fosfomycin Sodium Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Fosfomycin Sodium Product Image Figure 2. Global Fosfomycin Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fosfomycin Sodium Sales (2021-2032) & (k units) Figure 5. Global Fosfomycin Sodium Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Fosfomycin Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Global Fosfomycin Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Fosfomycin Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fosfomycin Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Fosfomycin Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fosfomycin Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fosfomycin Sodium Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Fosfomycin Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Fosfomycin Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Fosfomycin Sodium Sales Volume Share by Application (2021-2032) Figure 23. Global Fosfomycin Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Fosfomycin Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Fosfomycin Sodium Sales Value Share by Application (2021-2032) Figure 26. Global Fosfomycin Sodium Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Fosfomycin Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Fosfomycin Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Fosfomycin Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 31. North America Fosfomycin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Fosfomycin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Fosfomycin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 37. South America Fosfomycin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Fosfomycin Sodium Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Fosfomycin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Fosfomycin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Fosfomycin Sodium Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Fosfomycin Sodium Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • New Asia Pharma
  • Dorrapharma
  • Merck KGaA
  • FarmaSino Pharmaceutical
  • Hubei Xunda Pharmaceutical
  • Northeast Pharma
  • Sundent Pharm Group
  • Shin Poong Pharm
  • National Analytical Corporation
  • Ercros

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fosfomycin Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Fosfomycin Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Fosfomycin Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fosfomycin Sodium Market Dynamics
  1. 2.1 Fosfomycin Sodium Industry Trends
  2. 2.2 Fosfomycin Sodium Industry Drivers
  3. 2.3 Fosfomycin Sodium Industry Opportunities and Challenges
  4. 2.4 Fosfomycin Sodium Industry Restraints
3 Fosfomycin Sodium Market by Company
  1. 3.1 Global Fosfomycin Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Fosfomycin Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Fosfomycin Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Fosfomycin Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Fosfomycin Sodium Company Ranking (2024-2026)
  6. 3.6 Global Fosfomycin Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Fosfomycin Sodium Company Product Type and Application
  8. 3.8 Global Fosfomycin Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fosfomycin Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fosfomycin Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fosfomycin Sodium Market by Type
  1. 4.1 Fosfomycin Sodium Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injection
  4. 4.2 Global Fosfomycin Sodium Sales Volume by Type
  5. 4.2.1 Global Fosfomycin Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fosfomycin Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fosfomycin Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fosfomycin Sodium Sales Value by Type
  9. 4.3.1 Global Fosfomycin Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fosfomycin Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fosfomycin Sodium Sales Value Share by Type (2021-2032)
5 Fosfomycin Sodium Market by Application
  1. 5.1 Fosfomycin Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Fosfomycin Sodium Sales Volume by Application
  6. 5.2.1 Global Fosfomycin Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fosfomycin Sodium Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Fosfomycin Sodium Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Fosfomycin Sodium Sales Value by Application
  10. 5.3.1 Global Fosfomycin Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fosfomycin Sodium Sales Value by Application (2021-2032)
  12. 5.3.3 Global Fosfomycin Sodium Sales Value Share by Application (2021-2032)
6 Fosfomycin Sodium Regional Sales and Value Analysis
  1. 6.1 Global Fosfomycin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fosfomycin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Fosfomycin Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Fosfomycin Sodium Sales by Region (2027-2032)
  5. 6.3 Global Fosfomycin Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fosfomycin Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fosfomycin Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fosfomycin Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Fosfomycin Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fosfomycin Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Fosfomycin Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fosfomycin Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Fosfomycin Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fosfomycin Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fosfomycin Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fosfomycin Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Fosfomycin Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fosfomycin Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fosfomycin Sodium Sales Value Share by Country, 2025 VS 2032
7 Fosfomycin Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Fosfomycin Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fosfomycin Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fosfomycin Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Fosfomycin Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Fosfomycin Sodium Sales by Country (2027-2032)
  6. 7.4 Global Fosfomycin Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fosfomycin Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fosfomycin Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fosfomycin Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fosfomycin Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fosfomycin Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 New Asia Pharma
  2. 8.1.1 New Asia Pharma Company Information
  3. 8.1.2 New Asia Pharma Business Overview
  4. 8.1.3 New Asia Pharma Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 New Asia Pharma Fosfomycin Sodium Product Portfolio
  6. 8.1.5 New Asia Pharma Recent Developments
  7. 8.2 Dorrapharma
  8. 8.2.1 Dorrapharma Company Information
  9. 8.2.2 Dorrapharma Business Overview
  10. 8.2.3 Dorrapharma Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dorrapharma Fosfomycin Sodium Product Portfolio
  12. 8.2.5 Dorrapharma Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Fosfomycin Sodium Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 FarmaSino Pharmaceutical
  20. 8.4.1 FarmaSino Pharmaceutical Company Information
  21. 8.4.2 FarmaSino Pharmaceutical Business Overview
  22. 8.4.3 FarmaSino Pharmaceutical Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio
  24. 8.4.5 FarmaSino Pharmaceutical Recent Developments
  25. 8.5 Hubei Xunda Pharmaceutical
  26. 8.5.1 Hubei Xunda Pharmaceutical Company Information
  27. 8.5.2 Hubei Xunda Pharmaceutical Business Overview
  28. 8.5.3 Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio
  30. 8.5.5 Hubei Xunda Pharmaceutical Recent Developments
  31. 8.6 Northeast Pharma
  32. 8.6.1 Northeast Pharma Company Information
  33. 8.6.2 Northeast Pharma Business Overview
  34. 8.6.3 Northeast Pharma Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Northeast Pharma Fosfomycin Sodium Product Portfolio
  36. 8.6.5 Northeast Pharma Recent Developments
  37. 8.7 Sundent Pharm Group
  38. 8.7.1 Sundent Pharm Group Company Information
  39. 8.7.2 Sundent Pharm Group Business Overview
  40. 8.7.3 Sundent Pharm Group Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sundent Pharm Group Fosfomycin Sodium Product Portfolio
  42. 8.7.5 Sundent Pharm Group Recent Developments
  43. 8.8 Shin Poong Pharm
  44. 8.8.1 Shin Poong Pharm Company Information
  45. 8.8.2 Shin Poong Pharm Business Overview
  46. 8.8.3 Shin Poong Pharm Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shin Poong Pharm Fosfomycin Sodium Product Portfolio
  48. 8.8.5 Shin Poong Pharm Recent Developments
  49. 8.9 National Analytical Corporation
  50. 8.9.1 National Analytical Corporation Company Information
  51. 8.9.2 National Analytical Corporation Business Overview
  52. 8.9.3 National Analytical Corporation Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 National Analytical Corporation Fosfomycin Sodium Product Portfolio
  54. 8.9.5 National Analytical Corporation Recent Developments
  55. 8.10 Ercros
  56. 8.10.1 Ercros Company Information
  57. 8.10.2 Ercros Business Overview
  58. 8.10.3 Ercros Fosfomycin Sodium Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ercros Fosfomycin Sodium Product Portfolio
  60. 8.10.5 Ercros Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fosfomycin Sodium Value Chain Analysis
  2. 9.1.1 Fosfomycin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fosfomycin Sodium Sales Mode & Process
  6. 9.2 Fosfomycin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fosfomycin Sodium Distributors
  9. 9.2.3 Fosfomycin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst